Search Results 1481-1490 of 14777 for anti-TNF drugs

1. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...

2. Sodium Phenylacetate And Benzoate (Intravenous Route) Precautions - Mayo Clinic

   Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your or your child's progress closely while ...

3. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Received monoclonal antibodies targeting cytokines (e.g., tumor necrosis factor (TNF) inhibitors, anti-IL-1 [e.g., anakinra, canakinumab], anti-IL-6 [e.g. ...

4. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

   APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis · Overview · Participation ...

5. Anti-Aging Archives - Mayo Clinic News Network

   Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and ...

6. Cabotegravir And Rilpivirine (Intramuscular Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

   ... anti-neoplastic therapy; At least 18 years of age; Able to understand and sign an informed consent (or have a legal representative who is able to do so) ...

8. Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl (Intravenous Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. A nurse or other trained health professional will give you this medicine in a hospital or ...

9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...

10. CardiovascularUpdate

    tended to be a drug target. Tyrosine kinase inhibitors are common anti- neoplastic agents and are of 2 types: small mol- ecule kinase inhibitors, which ...